Paper42290657
SIRT5 mediates the pro-osteogenic effects of estrogen through FDX1 demalonylation and cuproptosis inhibition in mesenchymal stem cells.
Ye F and 9 others. Genes Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. SIRT5 mediates the pro-osteogenic effects of estrogen through FDX1 demalonylation and cuproptosis inhibition in mesenchymal stem cells. Papers, record 42290657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42290657
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- SIRT5 mediates the pro-osteogenic effects of estrogen through FDX1 demalonylation and cuproptosis inhibition in mesenchymal stem cells.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23571522 | Zinc as a nutritional approach to bone loss prevention in an ovariectomized rat model. | Menopause | 2013 | https://conductscience.org/library/papers/23571522 | PubMed |
| 2 | 34245764 | Metabolic Rewiring by Loss of Sirt5 Promotes Kras-Induced Pancreatic Cancer Progression. | Gastroenterology | 2021 | https://conductscience.org/library/papers/34245764 | PubMed |
| 3 | 35436671 | Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors. | Eur J Med Chem | 2022 | https://conductscience.org/library/papers/35436671 | PubMed |
| 4 | 38599063 | Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases. | Biomed Pharmacother | 2024 | https://conductscience.org/library/papers/38599063 | PubMed |
| 5 | 35480856 | Promoting osteointegration effect of Cu-alloyed titanium in ovariectomized rats. | Regen Biomater | 2022 | https://conductscience.org/library/papers/35480856 | PubMed |
| 6 | 38599595 | SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration. | Biofactors | 2024 | https://conductscience.org/library/papers/38599595 | PubMed |
| 7 | 30215866 | Intersection of Iron and Copper Metabolism in the Mammalian Intestine and Liver. | Compr Physiol | 2018 | https://conductscience.org/library/papers/30215866 | PubMed |
| 8 | 24949665 | The Sirtuin1 activator SRT3025 down-regulates sclerostin and rescues ovariectomy-induced bone loss and biomechanical deterioration in female mice. | Endocrinology | 2014 | https://conductscience.org/library/papers/24949665 | PubMed |
| 9 | 23797848 | Copper deficit as a potential pathogenic factor of reduced bone mineral density and severe tooth wear. | Osteoporos Int | 2014 | https://conductscience.org/library/papers/23797848 | PubMed |
| 10 | 38318808 | Sirtuins: exploring next-gen therapeutics in the pathogenesis osteoporosis and associated diseases. | Immunopharmacol Immunotoxicol | 2024 | https://conductscience.org/library/papers/38318808 | PubMed |
| 11 | 36848556 | FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery. | Proc Natl Acad Sci U S A | 2023 | https://conductscience.org/library/papers/36848556 | PubMed |
| 12 | 20117961 | Human copper homeostasis: a network of interconnected pathways. | Curr Opin Chem Biol | 2010 | https://conductscience.org/library/papers/20117961 | PubMed |
| 13 | 36653443 | SIRT5-related desuccinylation modification of AIFM1 protects against compression-induced intervertebral disc degeneration by regulating mitochondrial homeostasis. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/36653443 | PubMed |
| 14 | 34210051 | Copper as Dietary Supplement for Bone Metabolism: A Review. | Nutrients | 2021 | https://conductscience.org/library/papers/34210051 | PubMed |
| 15 | 22595550 | Estrogen and the skeleton. | Trends Endocrinol Metab | 2012 | https://conductscience.org/library/papers/22595550 | PubMed |
| 16 | 11581496 | Mechanisms of estrogen action. | Physiol Rev | 2001 | https://conductscience.org/library/papers/11581496 | PubMed |
| 17 | 38264287 | Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/38264287 | PubMed |
| 18 | 40523885 | Membrane-initiated estrogen receptor-α signaling in osteoblasts is crucial for normal regulation of the cortical bone in female mice. | Bone Res | 2025 | https://conductscience.org/library/papers/40523885 | PubMed |
| 19 | 28880264 | Knockdown of SIRT7 enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly via activation of the Wnt/β-catenin signaling pathway. | Cell Death Dis | 2017 | https://conductscience.org/library/papers/28880264 | PubMed |
| 20 | 40322223 | SIRT5 promotes the osteo-inductive potential of BMP9 by stabilizing the HIF-1α protein in mouse embryonic fibroblasts. | Genes Dis | 2025 | https://conductscience.org/library/papers/40322223 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FDX1 | 2230 | PubTator's text mining | https://conductscience.org/library/genes/2230 | NCBI Gene |
| SIRT5 | 23408 | PubTator's text mining | https://conductscience.org/library/genes/23408 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42290657
GET https://conductscience.org/api/papers/v1/42290657/references?page=2